Create an alert
to follow the executive moves at ChemoCentryx.
Merck has announced the acquisition of ArQule (posted on Dec 9, 2019).
Astellas Pharma has announced the acquisition of Audentes Therapeutics (posted on Dec 5, 2019).
Mesa Laboratories has announced the acquisition of Gyros (posted on Nov 1, 2019).
ChemoCentryx and VFMCRP Announce Positive Topline Data from Pivotal Phase III ADVOCATE Trial Demonstrating Avacopan’s Superiority Over Standard of Care in ANCA-Associated Vasculitis | ChemoCentryx, Inc.
ChemoCentryx to Present at the 31st Annual Piper Jaffray Healthcare Conference | ChemoCentryx, Inc.
Presentations at ASN Kidney Week 2019 Highlight Breadth of ChemoCentryx Platform in Treatment of Complement 3 Glomerulopathy (C3G) and Focal Segmental Glomerulosclerosis (FSGS) | ChemoCentryx, Inc.
ChemoCentryx Reports Third Quarter 2019 Financial Results and Recent Highlights | ChemoCentryx, Inc.
ChemoCentryx to Present at the Canaccord Genuity 39th Annual Growth Conference | ChemoCentryx, Inc.
Learn about your clients' org charts. Understand their industries and their competitors.
View the executives' biographies. Contact the executives through our email platform.
Select key words to follow your clients. Receive alerts when executive movements happen.
File your clients in folders. Add private notes. Download our data in Excel on your PC.